GlaxoSmithKline's investors have come around on Tesaro deal, executive says

23rd January 2019 Uncategorised 0

GSK investors cheered when the company said it would finally spin off its consumer unit after swallowing Pfizer’s. But its other December deal—a $5 billion Tesaro buyout—didn’t sit quite so well. Now, it’s a different story, one executive said in an interview.

More: GlaxoSmithKline's investors have come around on Tesaro deal, executive says
Source: fierce